Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

Improved Travel With Coronavirus Testing

Reduce the risk of facing restrictions and quarantine measures at your destination with SARS-CoV-2 pre-flight testing

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Centogene’s latest Scientific Publications

Genetic Cause of Impaired Neurodevelopment

Development of the nervous system is a complex process, with NEUROG1 being one out of many…

Exemplifying the High Value of CentoMD®

Rare disease research usually focuses on pathogenic genetic variants. The lack of a…

A Rare Genetic Disease in Which Symptoms Naturally Improve

While most genetic disorders progress from mild to severe, a certain form of muscle…

Genetic Stratification of Patients with Parkinson’s Disease

While Parkinson’s disease (PD) is clinically homogeneous, it can result from a multitude…

Disturbed Growth Signaling Linked to a Novel Disorder

Most studies that report novel gene-disease associations lack functional insights. A…

An Extended Intellectual Disability Phenotype

Intellectual disability (ID) is amongst the most frequent symptoms of syndromic genetic…

Defective mRNA Translation and Neurodegeneration

Based on their size and inability to renew, nerve cells are highly vulnerable to defects…

Genetic Confirmation to Solidify Expert Clinical Suspicion

Expert physicians are able to clinically recognize even rare congenital conditions. In…

A Case Report with High Scientific Value

The value of a case report can be correlated with the rarity of the disorder it covers. A…

Joining Forces to Understand Ultra-Rare Disorders

Certain genetic disorders are too rare to be investigated in several patients by single…

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 18. Januar 2021

  • Das Walk-In-Testzentrum im Flughafen Düsseldorf wurde vom Terminal C zur...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 12. Januar 2021

  • Seit dem 11. Januar 2021 gilt bundesweit für Reiserückkehrer aus Risikogebieten...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 18, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 18. Dezember 2020

  • Der zentrale Standort des Testcenters erleichtert den Zugang zu zuverlässigen und...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 16, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 15. Dezember 2020

  • Die zentrale Lage des Testcenter erleichtert den Zugang zu sicheren und schnellen...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 09, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN and MUNICH, Germany, December 08, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK, BERLIN & MÜNCHEN, Deutschland, 08. Dezember 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), ein wirtschaftliches...

Read more